Avastin plus chemo better without Erbitux
CHICAGO (Reuters) - Colon cancer patients treated with Genentech Inc’s Avastin and chemotherapy lived longer without their disease getting worse than those who were also treated with ImClone Systems Inc’s Erbitux, according to a study presented on Saturday.
More: continued here
Leave a Reply
You must be logged in to post a comment.